<drug type="small molecule" created="2015-11-30" updated="2017-04-01">
  <drugbank-id primary="true">DB09422</drugbank-id>
  <name>Soybean oil</name>
  <description/>
  <cas-number/>
  <unii>241ATL177A</unii>
  <groups>
    <group>approved</group>
  </groups>
  <general-references>
    <articles/>
    <textbooks/>
    <links/>
  </general-references>
  <synthesis-reference/>
  <indication/>
  <pharmacodynamics/>
  <mechanism-of-action/>
  <toxicity/>
  <metabolism/>
  <absorption/>
  <half-life/>
  <protein-binding/>
  <route-of-elimination/>
  <volume-of-distribution/>
  <clearance/>
  <salts/>
  <synonyms/>
  <products>
    <product>
      <name>Clinoleic 20%</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02344327</dpd-id>
      <started-marketing-on>2012-03-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Emulsion</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinolipid</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-9540</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2016-01-01</started-marketing-on>
      <ended-marketing-on>2017-02-03</ended-marketing-on>
      <dosage-form>Injection, emulsion</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA204508</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Essenherb Soybean 90 Deep Cleansing</name>
      <labeller>Ami Cosmetic Co.,Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code>59535-1661</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2015-06-11</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Oil</dosage-form>
      <strength>91.6 g/100mL</strength>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Intralipid</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-0519</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2004-04-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Emulsion</dosage-form>
      <strength>20 g/100mL</strength>
      <route>Intravenous</route>
      <fda-application-number>NDA018449</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Intralipid</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-0520</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2004-04-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Emulsion</dosage-form>
      <strength>30 g/100mL</strength>
      <route>Intravenous</route>
      <fda-application-number>NDA019942</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Intralipid</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-0518</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2004-04-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Emulsion</dosage-form>
      <strength>10 g/100mL</strength>
      <route>Intravenous</route>
      <fda-application-number>NDA017643</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Intralipid 10%</name>
      <labeller>Fresenius Kabi</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02065681</dpd-id>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Emulsion</dosage-form>
      <strength>10 %</strength>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Intralipid 20%</name>
      <labeller>Fresenius Kabi</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02065673</dpd-id>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Emulsion</dosage-form>
      <strength>20 %</strength>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Intralipid 30%</name>
      <labeller>Fresenius Kabi</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02216175</dpd-id>
      <started-marketing-on>1996-12-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Emulsion</dosage-form>
      <strength>30 %</strength>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Liposyn II</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-9786</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1984-08-27</started-marketing-on>
      <ended-marketing-on>2016-01-29</ended-marketing-on>
      <dosage-form>Injection, emulsion</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA018997</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Liposyn II</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-9789</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1984-08-27</started-marketing-on>
      <ended-marketing-on>2016-01-29</ended-marketing-on>
      <dosage-form>Injection, emulsion</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA018991</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Liposyn III</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-9790</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-02-11</started-marketing-on>
      <ended-marketing-on>2016-02-26</ended-marketing-on>
      <dosage-form>Injection, emulsion</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA018969</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Liposyn III</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-9791</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-02-11</started-marketing-on>
      <ended-marketing-on>2016-02-26</ended-marketing-on>
      <dosage-form>Injection, emulsion</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA018970</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Nutrilipid I.V. Fat Emulsion</name>
      <labeller>B. Braun Medical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0264-4460</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2014-06-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>20 g/100mL</strength>
      <route>Intravenous</route>
      <fda-application-number>NDA019531</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Phytolecithine D</name>
      <labeller>Phyto Health Corporation</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00290912</dpd-id>
      <started-marketing-on>1973-12-31</started-marketing-on>
      <ended-marketing-on>2003-11-27</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>SPF 30 Sunscreen</name>
      <labeller>Shanghai Kejing Cleaning Products Co., Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code>31190-330</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2016-06-25</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Spray</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number>part352</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
  </products>
  <international-brands/>
  <mixtures>
    <mixture>
      <name>Nutrilipid I.V. Fat Emulsion</name>
      <ingredients>Soybean oil</ingredients>
    </mixture>
    <mixture>
      <name>Intralipid 10%</name>
      <ingredients>Soybean oil</ingredients>
    </mixture>
    <mixture>
      <name>Clinoleic 20%</name>
      <ingredients>Soybean oil + Olive oil</ingredients>
    </mixture>
    <mixture>
      <name>Intralipid 20%</name>
      <ingredients>Soybean oil</ingredients>
    </mixture>
    <mixture>
      <name>Phytolecithine D</name>
      <ingredients>Soybean + Soybean oil + Vitamin d</ingredients>
    </mixture>
    <mixture>
      <name>Liposyn II</name>
      <ingredients>Safflower oil + Soybean oil</ingredients>
    </mixture>
    <mixture>
      <name>Liposyn II</name>
      <ingredients>Safflower oil + Soybean oil</ingredients>
    </mixture>
    <mixture>
      <name>Liposyn III</name>
      <ingredients>Soybean oil</ingredients>
    </mixture>
    <mixture>
      <name>Liposyn III</name>
      <ingredients>Soybean oil</ingredients>
    </mixture>
    <mixture>
      <name>Intralipid 30%</name>
      <ingredients>Soybean oil</ingredients>
    </mixture>
    <mixture>
      <name>Clinolipid</name>
      <ingredients>Olive oil + Soybean oil</ingredients>
    </mixture>
    <mixture>
      <name>Essenherb Soybean 90 Deep Cleansing</name>
      <ingredients>Soybean oil</ingredients>
    </mixture>
    <mixture>
      <name>SPF 30 Sunscreen</name>
      <ingredients>Octinoxate + Soybean oil + Octisalate + Oxybenzone + Titanium dioxide</ingredients>
    </mixture>
    <mixture>
      <name>Intralipid</name>
      <ingredients>Soybean oil</ingredients>
    </mixture>
    <mixture>
      <name>Intralipid</name>
      <ingredients>Soybean oil</ingredients>
    </mixture>
    <mixture>
      <name>Intralipid</name>
      <ingredients>Soybean oil</ingredients>
    </mixture>
  </mixtures>
  <packagers/>
  <manufacturers/>
  <prices/>
  <categories>
    <category>
      <category>Biological Products</category>
      <mesh-id>D001688</mesh-id>
    </category>
    <category>
      <category>Complex Mixtures</category>
      <mesh-id>D045424</mesh-id>
    </category>
    <category>
      <category>Diet, Food, and Nutrition</category>
      <mesh-id>D000066888</mesh-id>
    </category>
    <category>
      <category>Dietary Fats</category>
      <mesh-id>D004041</mesh-id>
    </category>
    <category>
      <category>Dietary Fats, Unsaturated</category>
      <mesh-id>D004042</mesh-id>
    </category>
    <category>
      <category>Fats</category>
      <mesh-id>D005223</mesh-id>
    </category>
    <category>
      <category>Fats, Unsaturated</category>
      <mesh-id>D005224</mesh-id>
    </category>
    <category>
      <category>Food</category>
      <mesh-id>D005502</mesh-id>
    </category>
    <category>
      <category>Food and Beverages</category>
      <mesh-id>D019602</mesh-id>
    </category>
    <category>
      <category>Lipids</category>
      <mesh-id>D008055</mesh-id>
    </category>
    <category>
      <category>Oils</category>
      <mesh-id>D009821</mesh-id>
    </category>
    <category>
      <category>Physiological Phenomena</category>
      <mesh-id>D010829</mesh-id>
    </category>
    <category>
      <category>Plant Oils</category>
      <mesh-id>D010938</mesh-id>
    </category>
    <category>
      <category>Plant Preparations</category>
      <mesh-id>D028321</mesh-id>
    </category>
  </categories>
  <affected-organisms/>
  <dosages>
    <dosage>
      <form>Emulsion</form>
      <route>Intravenous</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Oil</form>
      <route>Topical</route>
      <strength>91.6 g/100mL</strength>
    </dosage>
    <dosage>
      <form>Emulsion</form>
      <route>Intravenous</route>
      <strength>10 g/100mL</strength>
    </dosage>
    <dosage>
      <form>Emulsion</form>
      <route>Intravenous</route>
      <strength>20 g/100mL</strength>
    </dosage>
    <dosage>
      <form>Emulsion</form>
      <route>Intravenous</route>
      <strength>30 g/100mL</strength>
    </dosage>
    <dosage>
      <form>Emulsion</form>
      <route>Intravenous</route>
      <strength>10 %</strength>
    </dosage>
    <dosage>
      <form>Emulsion</form>
      <route>Intravenous</route>
      <strength>20 %</strength>
    </dosage>
    <dosage>
      <form>Emulsion</form>
      <route>Intravenous</route>
      <strength>30 %</strength>
    </dosage>
    <dosage>
      <form>Injection, emulsion</form>
      <route>Intravenous</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous</route>
      <strength>20 g/100mL</strength>
    </dosage>
    <dosage>
      <form>Capsule</form>
      <route>Oral</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Spray</form>
      <route>Topical</route>
      <strength/>
    </dosage>
  </dosages>
  <atc-codes/>
  <ahfs-codes/>
  <pdb-entries/>
  <patents>
    <patent>
      <number>5840757</number>
      <country>United States</country>
      <approved>1995-11-24</approved>
      <expires>2015-11-24</expires>
      <pediatric-extension>false</pediatric-extension>
    </patent>
  </patents>
  <food-interactions/>
  <drug-interactions/>
  <calculated-properties/>
  <experimental-properties/>
  <external-identifiers>
    <external-identifier>
      <resource>Drugs Product Database (DPD)</resource>
      <identifier>3289</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links/>
  <pathways/>
  <reactions/>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets/>
  <enzymes/>
  <carriers/>
  <transporters/>
</drug>
